Targeting Neutrophil Extracellular Traps (NETs)
NETs are a driver of cancer progression and metastasis and can also contribute to resistance to chemotherapy, checkpoint inhibitors and radiotherapy.
DNase I Oncology Platform
Oncology platform aimed at improving cancer therapies with the opportunity to address multiple oncology indications, including pancreatic cancer and other solid tumors.
PipelineStock Information
Nasdaq: XBIO
Xenetic Biosciences, Inc.
Price
Change
Volume
Day Range
52 Week Range
